Les Meilleurs doctors pour le traitement de cancer du foie stade 2 en Israël - TOP-18 des médecins

Le Dr Pelles Sharon se spécialise dans les traitements complexes du cancer du foie, y compris des techniques avancées telles que la thérapie SIRT et la résection hépatique au centre médical Sourasky.

• Oncologue respecté avec d'importantes contributions à la recherche clinique
• Proposer des traitements innovants tels que la chimiothérapie intrapéritonéale hyperthermique (HIPEC)
• Expert en chimiothérapie pour le cancer du foie et en ablation par radiofréquence
• Offrir des soins complets avec des options de thérapie ciblée et d'immunothérapie

Le Pr Merimsky dirige l'Unité d'oncologie des tissus mous et des os au Sourasky Medical Center – l'un des meilleurs centres de traitement du cancer en Israël.

• Plus de 25 ans de spécialisation dans les cas oncologiques complexes
• Formation complémentaire (Fellowship) à l'Institut Gustave Roussy pour le traitement des sarcomes
• Vice-président du comité d'éthique de l'hôpital
• Publication de nombreux articles sur les tumeurs osseuses et des tissus mous
• Membre de la faculté du groupe Sarcome de l'ESMO

Plus de 30 ans d'expérience centrée sur les cancers gastro-intestinaux. Il dirige le centre de prévention du cancer au centre médical Sourasky (Ichilov).

• Spécialisé exclusivement dans la prévention, le diagnostic précoce et le traitement des tumeurs gastro-intestinales
• Auteur de plus de 300 articles scientifiques publiés sur l'oncologie gastro-intestinale
• Travaux de recherche effectués au centre NewYork-Presbyterian aux États-Unis
• Formation spécialisée en gastro-entérologie à la faculté de médecine Sackler de l'université de Tel Aviv
• Membre de sociétés internationales telles que l'European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dirige la division d'oncologie médicale du centre médical Sourasky, l'un des principaux hôpitaux d'Israël. Il possède une expérience spécifique en oncologie et en médecine interne.

• Certifié par le conseil de l'ordre avec une formation approfondie, notamment au sein d'unités médicales de l'armée
• Rôle de direction supervisant tous les protocoles de traitement du cancer
• Diplôme de médecine de l'université Ben Gourion du Néguev
• Spécialisation dans les traitements systémiques du cancer et la coordination des thérapies

Spécialiste de premier plan de l'opération de Whipple et de la chirurgie abdominale mini-invasive, le Dr Greenberg dirige le département de chirurgie colorectale du centre médical Sourasky (Ichilov).

• Plus de 20 ans d'expérience en tant que chirurgien abdominal
• Pratiquer des techniques chirurgicales ouvertes et mini-invasives
• Expert en procédures complexes du pancréas et du foie, telles que l'opération de Whipple
• Diriger un département chirurgical spécialisé dans un hôpital majeur

Plus de 28 ans de spécialisation en chirurgie du cancer du foie – Le Dr Ben-haim figure parmi les meilleurs chirurgiens d'Israël pour les cancers gastro-intestinaux au centre médical Sourasky.

• Être expert en chirurgie de Whipple pour les cas complexes
• Se concentrer exclusivement sur les cancers du foie, du pancréas et gastro-intestinaux
• Réaliser des interventions avancées pour les pathologies oncologiques

Le Dr Auala Hubert dirige le centre de cancérologie gastro-intestinale du centre médical Hadassah, apportant 33 ans d'expertise ciblée en oncologie.

• Spécialisation en oncologie médicale et radiothérapie
• Chef du centre de cancérologie gastro-intestinale à Hadassah
• Certifié en oncologie et radiothérapie
• Membre de la Société israélienne d'oncologie clinique
• Maîtrise de l'anglais et de l'hébreu pour les patients internationaux

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Alexander Beny est un oncologue certifié possédant une vaste formation en oncologie médicale et en radiothérapie, spécialisé dans le cancer du foie au centre médical Rambam.

• Chef du service des tumeurs malignes gastro-intestinales au centre médical Rambam
• Formé en Italie et en Israël avec une certification du conseil européen
• Spécialisé dans les approches d'oncologie médicale et de radiothérapie
• Dirige des cliniques spécialisées en gastro-entérologie et en onco-gynécologie

Le Dr Zalmanova est spécialisée en radiothérapie au centre médical Assuta, se concentrant sur les traitements du cancer du foie.

• Radiothérapeute experte en cancer du foie de stade 2
• Travailler au centre médical Assuta, un établissement de santé de premier plan
• Se consacrer à des plans de traitement personnalisés pour chaque patient